Should Men with Serum Prostate-Specific Antigen ≤4 ng/ml and Normal Digital Rectal Examination Undergo a Prostate Biopsy?
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 81, doi. 10.1159/000092583
- By:
- Publication type:
- Article
Works matching IS 00302414 AND DT 2006 AND VI 70 AND IP 2
Results: 12
1
2
CBHA Is a Family of Hybrid Polar Compounds That Inhibit Histone Deacetylase, and Induces Growth Inhibition, Cell Cycle Arrest and Apoptosis in Human Endometrial and Ovarian Cancer Cells.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 97, doi. 10.1159/000092585
- By:
- Publication type:
- Article
3
The Prognostic Determinants of Gastric Cancer Treatment Outcome in Omani Arab Patients.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 90, doi. 10.1159/000092584
- By:
- Publication type:
- Article
4
Multicenter Phase II Study of Gemcitabine and Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Colorectal Cancer Patients Pretreated with 5-Fluorouracil plus Irinotecan.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 106, doi. 10.1159/000092956
- By:
- Publication type:
- Article
5
Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 115, doi. 10.1159/000093002
- By:
- Publication type:
- Article
6
Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric Carcinoma.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 126, doi. 10.1159/000093003
- By:
- Publication type:
- Article
7
A Phase II Study of Irinotecan with 5-Fluorouracil and Leucovorin in Patients with Pretreated Gastroenteropancreatic Well-Differentiated Endocrine Carcinomas.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 134, doi. 10.1159/000093004
- By:
- Publication type:
- Article
8
Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 141, doi. 10.1159/000093005
- By:
- Publication type:
- Article
9
Zoledronic Acid (Zometa) Enhances the Cytotoxic Effect of Gemcitabine and Fluvastatin: In vitro Isobologram Studies with Conventional and Nonconventional Cytotoxic Agents.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 147, doi. 10.1159/000093006
- By:
- Publication type:
- Article
10
Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 154, doi. 10.1159/000093007
- By:
- Publication type:
- Article
11
Book Review.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
12
Book Review.
- Published in:
- 2006
- By:
- Publication type:
- Book Review